Allogene Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update
Allogene Therapeutics announced it will report its second quarter 2026 financial results and provide a business update on August 12, 2026, after the market close. The company will host a live audio webcast and conference call at 2:00 p.m. PT/5:00 p.m. ET on the same day to discuss the results.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.